# OnCo record alopecia-endocrine-therapy (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/alopecia-endocrine-therapy/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "alopecia-endocrine-therapy" ;
  schema:name "Endocrine-therapy-induced alopecia"@en ;
  schema:alternateName "endocrine therapy-induced alopecia"@en, "EIA"@en, "aromatase inhibitor hair thinning"@en, "tamoxifen hair thinning"@en ;
  schema:description "Gradual thinning at the parting and crown that builds over months on tamoxifen, an aromatase inhibitor or ovarian suppression. It is not the sudden shedding of chemotherapy, it lasts as long as the treatment does, and it is often dismissed because it is mild on a clinician's scale and not on the patient's."@en ;
  schema:url <https://onco.cc/terms/alopecia-endocrine-therapy/> ;
  schema:dateModified "2026-10-02"^^xsd:date ;
  schema:citation <https://doi.org/10.1001/jamadermatol.2018.0454>, <https://doi.org/10.1001/jamadermatol.2018.5071>, <https://doi.org/10.1016/j.jaad.2018.03.056> ;
  onco:related <https://onco.cc/terms/alopecia-persistent-chemotherapy/>, <https://onco.cc/terms/hair-anagen-effluvium/> ;
  onco:sections <https://onco.cc/fronts/rejuvenation/>, <https://onco.cc/fronts/supportive-care/>, <https://onco.cc/fronts/hormonal/> ;
  onco:technologies <https://onco.cc/technologies/minoxidil-chemotherapy-alopecia/>, <https://onco.cc/technologies/endocrine-therapy/> ;
  onco:drugs <https://onco.cc/drugs/tamoxifen/>, <https://onco.cc/drugs/letrozole/>, <https://onco.cc/drugs/exemestane/>, <https://onco.cc/drugs/anastrozole/> .